Associations of Blood Cardiovascular Biomarkers With Brain Free Water and Its Relationship to Cognitive Decline

BACKGROUND AND OBJECTIVES There is an increasing awareness of the "Heart-Brain Connection", whereby cardiovascular function is connected with cognition. Diffusion MRI studies reported higher brain free-water (FW) was associated with cerebrovascular disease (CeVD) and cognitive impairment. In current work, we investigated whether higher brain FW was related to blood cardiovascular biomarkers and whether FW mediated the associations between blood biomarkers and cognition. METHODS Participants recruited from two Singapore memory clinics between 2010 and 2015 underwent collection of blood samples and neuroimaging at baseline and longitudinal neuropsychological assessments up to 5 years. We examined the associations of blood cardiovascular biomarkers (high-sensitivity cardiac troponin-T (hs-cTnT), N-terminal pro-hormone B-type natriuretic peptide (NT-proBNP), growth/differentiation factor 15 (GDF-15)) with brain white matter (WM) and cortical grey matter (GM) FW derived from diffusion-MRI using whole brain voxel-wise general linear regression. We then assessed the relationships among baseline blood biomarkers, brain-FW, and cognitive decline using path models. RESULTS 308 older adults (76 no cognitive impairment, 134 cognitive impairment no dementia, and 98 Alzheimer's disease dementia and vascular dementia; mean [SD] age: 72.1 [8.3]) were included. We found that blood cardiovascular biomarkers were associated with higher FW in widespread WM regions and in specific GM networks including the default mode, executive control, and somatomotor networks at baseline (p < 0.01, family-wise error corrected). Baseline FW in widespread WM and network-specific GM fully mediated the associations of blood biomarkers with longitudinal cognitive decline over 5 years. Specifically, in GM, higher FW in the default mode network mediated the relationship with memory decline (hs-cTnT: β=-0.115, SE=0.034, p=0.001; NT-proBNP: β=-0.154, SE=0.046, p=0.001; GDF-15: β=-0.073, SE=0.027, p=0.006); in contrast, higher FW in the executive control network was responsible for executive function decline (hs-cTnT: β=-0.126, SE=0.039, p=0.001; NT-proBNP: β=-0.110, SE=0.038, p=0.004; GDF-15: β=-0.117, SE=0.035, p=0.001). Similar full mediation effects of brain FW were also identified for baseline cognition. DISCUSSION Results suggested a role of brain-FW in linking cardiovascular dysfunction to cognitive decline. These findings provide new evidence for brain-heart interactions, paving the way for prediction and monitoring of domain-specific cognitive trajectory.

[1]  C. Gerloff,et al.  Free-water diffusion MRI detects structural alterations surrounding white matter hyperintensities in the early stage of cerebral small vessel disease , 2022, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  H. Matsuda,et al.  Free water derived by multi‐shell diffusion MRI reflects tau/neuroinflammatory pathology in Alzheimer's disease , 2022, Alzheimer's & dementia.

[3]  N. Venketasubramanian,et al.  Association Between Cerebral Cortical Microinfarcts and Perilesional Cortical Atrophy on 3T MRI , 2021, Neurology.

[4]  N. Venketasubramanian,et al.  Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline, Cerebrovascular Disease, and Clinical Events , 2021, Stroke.

[5]  Elayna R. Seago,et al.  Water exchange rate across the blood‐brain barrier is associated with CSF amyloid‐β 42 in healthy older adults , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[6]  Robert I. Reid,et al.  Diffusion models reveal white matter microstructural changes with ageing, pathology and cognition , 2021, Brain communications.

[7]  T. Wong,et al.  White matter network damage mediates association between cerebrovascular disease and cognition , 2021, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  Nick A. Weaver,et al.  Small vessel disease more than Alzheimer's disease determines diffusion MRI alterations in memory clinic patients , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[9]  Denise C. Park,et al.  Age‐dependent amyloid deposition is associated with white matter alterations in cognitively normal adults during the adult life span , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[10]  Y. Béjot,et al.  Brain-Heart Interactions During Ischemic Processes , 2019, Stroke.

[11]  M. Lawton,et al.  Global brain inflammation in stroke , 2019, The Lancet Neurology.

[12]  J. Zhou,et al.  Amyloid and cerebrovascular burden divergently influence brain functional network changes over time , 2019, Neurology.

[13]  Jingjing Xu,et al.  Gray matter structural covariance networks changes along the Alzheimer's disease continuum , 2019, NeuroImage: Clinical.

[14]  Yng Miin Loke,et al.  White matter microstructural abnormalities and default network degeneration are associated with early memory deficit in Alzheimer’s disease continuum , 2019, Scientific Reports.

[15]  T. Wong,et al.  Alterations in Brain Network Topology and Structural-Functional Connectome Coupling Relate to Cognitive Impairment , 2018, Front. Aging Neurosci..

[16]  Martha Elizabeth Shenton,et al.  Advances in microstructural diffusion neuroimaging for psychiatric disorders , 2018, NeuroImage.

[17]  Robert I. Reid,et al.  Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging , 2018, Annals of neurology.

[18]  Cory B. Giles,et al.  Endothelial dysfunction and angiogenesis impairment in the ageing vasculature , 2018, Nature Reviews Cardiology.

[19]  Yng Miin Loke,et al.  Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer’s disease , 2018, Alzheimer's Research & Therapy.

[20]  C. DeCarli,et al.  CEREBRAL WHITE MATTER FREE WATER: A SENSITIVE BIOMARKER OF COGNITION AND FUNCTION , 2018, Alzheimer's & Dementia.

[21]  M. Ewers,et al.  Free water determines diffusion alterations and clinical status in cerebral small vessel disease , 2018, Alzheimer's & Dementia.

[22]  W. M. van der Flier,et al.  A more randomly organized grey matter network is associated with deteriorating language and global cognition in individuals with subjective cognitive decline , 2018, Human brain mapping.

[23]  O. Pasternak,et al.  Cortical microstructural changes along the Alzheimer's disease continuum , 2018, Alzheimer's & Dementia.

[24]  W. Jagust,et al.  Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity , 2017, Nature Communications.

[25]  Xin Xu,et al.  Influence of cerebrovascular disease on brain networks in prodromal and clinical Alzheimer’s disease , 2017, Brain : a journal of neurology.

[26]  Yasuyuki Taki,et al.  Global associations between regional gray matter volume and diverse complex cognitive functions: evidence from a large sample study , 2017, Scientific Reports.

[27]  Yng Miin Loke,et al.  Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer’s disease with and without cerebrovascular disease , 2017, Alzheimer's Research & Therapy.

[28]  Axel Montagne,et al.  Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease , 2017, Nature Reviews Neuroscience.

[29]  N. Venketasubramanian,et al.  Association Between Subclinical Cardiac Biomarkers and Clinically Manifest Cardiac Diseases With Cortical Cerebral Microinfarcts , 2017, JAMA neurology.

[30]  R. Geocadin,et al.  Heart-Brain Axis: Effects of Neurologic Injury on Cardiovascular Function. , 2017, Circulation research.

[31]  Ann-Christin Ostwaldt,et al.  DCE-MRI blood–brain barrier assessment in acute ischemic stroke , 2017, Neurology.

[32]  K. Meguro,et al.  Alzheimer's disease with cerebrovascular disease: current status in the Asia–Pacific region , 2016, Journal of internal medicine.

[33]  S. Khalsa,et al.  Clinical neurocardiology defining the value of neuroscience‐based cardiovascular therapeutics , 2016, The Journal of physiology.

[34]  Hanzhang Lu,et al.  Cerebral blood flow modulation insufficiency in brain networks in multiple sclerosis: A hypercapnia MRI study , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  X. Ji,et al.  White matter injury in ischemic stroke , 2016, Progress in Neurobiology.

[36]  J. O'Brien,et al.  Imaging of neuroinflammation in dementia: a review , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[37]  N. Venketasubramanian,et al.  Markers of Cardiac Dysfunction in Cognitive Impairment and Dementia , 2015, Medicine.

[38]  M. Glymour,et al.  Relationship between baseline brain metabolism measured using [18F]FDG PET and memory and executive function in prodromal and early Alzheimer’s disease , 2012, Brain Imaging and Behavior.

[39]  P. Gorelick,et al.  The Dementia of Cardiac Disease , 2012, Current Cardiology Reports.

[40]  B. Zlokovic Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[41]  W. Gao,et al.  Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside , 2011, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[42]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[43]  Marisa O. Hollinshead,et al.  The organization of the human cerebral cortex estimated by intrinsic functional connectivity. , 2011, Journal of neurophysiology.

[44]  A. Auchus,et al.  The Prognostic Effects of Poststroke Cognitive Impairment No Dementia and Domain-Specific Cognitive Impairments in Nondisabled Ischemic Stroke Patients , 2011, Stroke.

[45]  R. Sulkava,et al.  B-type natriuretic peptide as a predictor of declining cognitive function and dementia—a cohort study of an elderly general population with a 5-year follow-up , 2010, Annals of medicine.

[46]  N. Intrator,et al.  Free water elimination and mapping from diffusion MRI , 2009, Magnetic resonance in medicine.

[47]  B. Miller,et al.  Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.

[48]  Cumara B. O’Carroll,et al.  Cardioembolic Stroke , 2017, Continuum.

[49]  R. van Reekum,et al.  Comparability of the clinical diagnostic criteria for vascular dementia: a critical review. Part I. , 2008, The Journal of neuropsychiatry and clinical neurosciences.